IL6 and psoriasis: Furthermore, subcutaneous administration of the fused EVs in a psoriasis-like mouse model elevated expression of the M2 macrophage marker Arg1 and significantly reduced levels of inflammatory cytokines, including IL-1β, IL-6, and TNF-α, in affected skin [194].